Chimeric Polypeptides and Uses Thereof
US-2020399320-A1 · Dec 24, 2020 · US
Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K4/00 |
| Official title | Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof |
| Display label | Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof |
| Total patents | 89 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is growing.
| Year | Patents |
|---|---|
| 2015 | 8 |
| 2016 | 9 |
| 2017 | 10 |
| 2018 | 11 |
| 2019 | 11 |
| 2020 | 11 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 8 |
| 2024 | 5 |
| 2025 | 8 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Modified lipopolysaccharide glycoform and method of use
US-10864266-B2 · Dec 15, 2020 · US
Peptide tag and tagged protein including same
US-10808253-B2 · Oct 20, 2020 · US
Opioid receptor modulators
US-10766925-B2 · Sep 8, 2020 · US
Antimicrobial peptides and compositions, methods, articles & kits relating thereto
US-2020172570-A1 · Jun 4, 2020 · US
Modified lipopolysaccharide glycoform and method of use
US-2020121786-A1 · Apr 23, 2020 · US
Peptides and methods and uses thereof for modulating anaphase promoting complex (apc) activity
US-2020123558-A1 · Apr 23, 2020 · US
Nucleosides with antiviral and anticancer activity
US-2020095273-A1 · Mar 26, 2020 · US
Self-assembling amphiphilic peptides
US-10570172-B1 · Feb 25, 2020 · US
Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response
US-2020054741-A1 · Feb 20, 2020 · US
Modified lipopolysaccharide glycoform and method of use
US-10525126-B2 · Jan 7, 2020 · US
Methods of designing novel antibody mimetics for use in detecting antigens and as therapeutic agents
US-2019385705-A1 · Dec 19, 2019 · US
Programmable cas9-recombinase fusion proteins and uses thereof
US-2019367891-A1 · Dec 5, 2019 · US
Antibody-binding polypeptide, antibody-binding fusion polypeptide, and adsorption material
US-10450344-B2 · Oct 22, 2019 · US
Prodrugs of Chlorokynurenines
US-2019308934-A1 · Oct 10, 2019 · US
Opioid Receptor Modulators
US-2019112333-A1 · Apr 18, 2019 · US
A peptide with ability to penetrate cell membrane
US-2019111141-A1 · Apr 18, 2019 · US
Potassium channel blockers and use thereof in the treatment of autoimmune diseases
US-10246496-B2 · Apr 2, 2019 · US
Chimeric polypeptides and uses thereof
US-2019092818-A1 · Mar 28, 2019 · US
Alphaa-crystallin mimetic peptides and uses thereof
US-10220070-B2 · Mar 5, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K4/00?
- CPC C07K4/00 is the Cooperative Patent Classification code for “Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof.”
- How many patents are filed under CPC C07K4/00 (Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof)?
- Our database includes 89 publications tagged with this CPC code.
- Is patent activity under CPC C07K4/00 growing?
- Publication counts under this code: 5 in 2024 vs 8 in 2025 (latest complete years).